Eisai

Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech
Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech
BioPharma Dive
Biogen
Eisai
Alzheimer's disease
clinical trials
aducanumab
Flag link:
Eisai, Takeda and GARDP hunt for new antibiotics
Eisai, Takeda and GARDP hunt for new antibiotics
Pharmaforum
Eisai
Takeda
GARDP
antibiotics
R&D
Flag link:
Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease
Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease
Pharmaceutical Business Review
Eisai
Alzheimer's disease
E2814
clinical trials
University College London
Flag link:
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Fierce Pharma
FDA
drug reps
physicians
Eisai
Fycompa
drug marketing
Flag link:
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
Stat
Biogen
Eisai
BAN2401
Alzheimer's disease
Flag link:
Sleep Well, Wake Up Alert: Eisai and Purdue's Lemborexant Positive in Phase III Trial for Insomnia
Sleep Well, Wake Up Alert: Eisai and Purdue's Lemborexant Positive in Phase III Trial for Insomnia
BioSpace
Eisai
Purdue Pharma
lemborexant
insomnia
Flag link:
Bial and Eisai confirm effectiveness of epilepsy monotherapy Zebinix
Bial and Eisai confirm effectiveness of epilepsy monotherapy Zebinix
Pharmaceutical Business Review
Bial
Eisai
Zebinix
epilepsy
focal-onset epilepsy
Flag link:
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
China
Eisai
Merck
Lenvima
liver cancer
HCC
Flag link:
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Eisai
Merck
Lenvima
liver cancer
hepatocellular carcinoma
Flag link:
Biogen and Eisai Report Phase Ib Extension Data for Alzheimer’s Trial
Biogen and Eisai Report Phase Ib Extension Data for Alzheimer’s Trial
BioSpace
Biogen
Eisai
aducanumab
clinical trials
Alzheimer's disease
Flag link:
Eisai's weight-loss drug proves safe, but delivers no heart benefit
Eisai's weight-loss drug proves safe, but delivers no heart benefit
Biopharma Dive
Eisai
Belviq
New England Journal of Medicine
Flag link:
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
CP WIre
Eisai
Merck
Lenvima
hepatocellular carcinoma
Europe
Flag link:
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
Eisai
Merck
Lenvima
hepatocellular carcinoma
Flag link:
Eisai-Merck partnership picks up first-line Lenvima approval
Eisai-Merck partnership picks up first-line Lenvima approval
Biopharma Dive
FDA
Eisai
Merck
Lenvima
hepatocellular carcinoma
Flag link:
Japan's Eisai sets price tag of about $16,000 on liver cancer drug
Japan's Eisai sets price tag of about $16,000 on liver cancer drug
Yahoo/Reuters
Eisai
liver cancer
drug pricing
Lenvima
Flag link:
Why Biogen's Stock Ripped Higher in July
Why Biogen's Stock Ripped Higher in July
Motley Fool
Biogen
Eisai
BAN2401
Alzheimer's disease
Spinraza
Ionis Pharmaceuticals
Flag link:
Biogen’s high-stakes Alzheimer’s gamble is being roasted by the experts. Is the amyloid beta theory dead?
Biogen’s high-stakes Alzheimer’s gamble is being roasted by the experts. Is the amyloid beta theory dead?
Endpoints
Biogen
Eisai
BAN2401
Alzheimer's disease
Flag link:
FOCUS-Eisai/Biogen to advance Alzheimer's drug, provide fresh hope
FOCUS-Eisai/Biogen to advance Alzheimer's drug, provide fresh hope
Yahoo/Reuters
Biogen
Eisai
Alzheimer's disease
BAN2401
Flag link:
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Fierce Pharma
Merck
Eisai
Lenvima
kidney cancer
thyroid cancer
Flag link:
Why the Latest Alzheimer’s Drug Study Has So Many People Confused
Why the Latest Alzheimer’s Drug Study Has So Many People Confused
Fortune
Biogen
Eisai
BAN2401
clinical trials
Alzheimer's disease
Flag link:

Pages